TTK Healthcare Q4 Result: Q4 net profit zooms 59%, sales up 13% YoY

TTK Healthcare is a small cap company that recorded a market cap of ₹1,795.12 Cr during today's closing session. The shares ended today on a green note by 2.01% after quarterly numbers.

During the quarter ended March 2023, the company recorded net sales of ₹180.13 Cr up by 13.52% YoY from ₹158.67 Cr during the quarter ended March 2022. During Q4FY23, its net income stood at ₹195.75 Cr up by 19.45% YoY from ₹163.87 Cr in Q4FY22.

Its net expenses stood at ₹168.99 Cr during the quarter under review up by 6.90% YoY from ₹158.07 Cr during the year-ago quarter. TTK Healthcare said its net profit reached ₹16.94 Cr during Q4FY23 up by 59.66% YoY from ₹10.61 Cr in Q4FY22.

“The Board has recommended a dividend of Rs.10/- (100%) per Equity Share of Rs.10/- each for the financial year ended 31st March, 2023,” said TTK Healthcare in a stock exchange filing.

The company has reported a total income of Rs.773.44 crores during the financial year ended March 31, 2023 against Rs.615.57 crores during the financial year ended March 31, 2022, up by 25.65% YoY. During FY23 its net profit stood at ₹639.71 Cr up by 1,438.20% YoY from ₹41.58 Cr in FY22 and its EPS climbed by 1,438.29% YoY from ₹29.43 in 12MFY22 to ₹452.72 in 12MFY23.

The company’s earnings per equity share (For Continuing Operations) climbed from ₹2.99 to ₹14.45. The shares of TTK Healthcare closed today on the BSE at ₹1270.40 apiece up by 2.01% from the previous close of ₹1245.35.